Normalised operating profit before depreciation and amortisation (EBITDA) amounted to 38 million euro and is almost 38% higher on the year, Podravka said in a consolidated unaudited report to the Zagreb bourse.
In the first quarter, the Podravka group recorded revenue of 191.8 million euro, up 9.1%, on the year.
The revenue of its food segment increased 11.3% to 146.5 million euro, while the pharmaceuticals segment generated a revenue of 45.3 million euro, up 2.5% compared to January-March 2023.
Normalized operating expenses totalled 162.1 million euro, up 3.8% on the year.
Shares of the parent company of the group, Podravka d.d., traded 0.64% higher at 158 euro on intraday on Tuesday on the Zagreb bourse.
($ = 0.932 euro)